{"id":67493,"date":"2014-08-06T13:49:18","date_gmt":"2014-08-06T17:49:18","guid":{"rendered":"http:\/\/www.eugenesis.com\/new-recommendations-for-post-treatment-care-of-prostate-cancer-survivors\/"},"modified":"2014-08-06T13:49:18","modified_gmt":"2014-08-06T17:49:18","slug":"new-recommendations-for-post-treatment-care-of-prostate-cancer-survivors","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/new-recommendations-for-post-treatment-care-of-prostate-cancer-survivors.php","title":{"rendered":"New recommendations for post-treatment care of prostate cancer survivors"},"content":{"rendered":"<p><p>    PUBLIC RELEASE DATE:  <\/p>\n<p>    4-Aug-2014  <\/p>\n<p>    Contact: Kathryn Ryan    <a href=\"mailto:kryan@liebertpub.com\">kryan@liebertpub.com<\/a>    914-740-2100    Mary Ann Liebert, Inc.\/Genetic    Engineering News<\/p>\n<p>    New Rochelle, NY, August 4, 2014 -- Many of the more than 2.5    million men in the U.S. who have received treatment for    prostate cancer deal with the often disabling side effects of    surgery and radiation and hormonal therapies. To aid in the    transition of these patients from specialty to primary care for    long-term management of problems such as urinary incontinence    and sexual and bowel dysfunction, updated guidelines for    prostate cancer survivorship care are published in Journal    of Men's Health, a peer-reviewed publication from Mary Ann    Liebert, Inc., publishers. The article is available free on the    Journal of Men's Health website at <a href=\"http:\/\/online.liebertpub.com\/doi\/full\/10.1089\/jomh.2014.0026\" rel=\"nofollow\">http:\/\/online.liebertpub.com\/doi\/full\/10.1089\/jomh.2014.0026<\/a>    until September 4, 2014.  <\/p>\n<p>    Ted Skolarus, MD, MPH led a team of authors from University of    Michigan, VA Ann Arbor Healthcare System, University of    Michigan Comprehensive Cancer Center (Ann Arbor), and Michigan    State University (East Lansing) in preparing the article    \"Recommendations for Prostate Cancer Survivorship Care: An    Update to the 2009 Michigan Cancer Consortium Guidelines for    the Primary Care Management of Prostate Cancer Post-Treatment    Sequelae.\" Based on information gathered from an expert panel    and focus groups, additions to the updated guidelines include    patient-reported symptoms assessment, self-management    strategies for treatment-related side effects, recommendations    for involving partners in survivorship care, and new care    coordination strategies.  <\/p>\n<p>    ###  <\/p>\n<p>    About the Journal  <\/p>\n<p>    Journal of Men's Health is the premier peer-reviewed    journal published quarterly in print and online that covers all    aspects of men's health across the lifespan. The Journal    publishes cutting-edge advances in a wide range of diseases and    conditions, including diagnostic procedures, therapeutic    management strategies, and innovative clinical research in    gender-based biology to ensure optimal patient care. The    Journal addresses disparities in health and life expectancy    between men and women; increased risk factors such as smoking,    alcohol abuse, and obesity; higher prevalence of diseases such    as heart disease and cancer; and health care in underserved and    minority populations. Journal of Men's Health meets the    critical imperative for improving the health of men around the    globe and ensuring better patient outcomes. Tables of content    and a sample issue can be viewed on the Journal of Men's    Health website at <a href=\"http:\/\/www.liebertpub.com\/jmh\" rel=\"nofollow\">http:\/\/www.liebertpub.com\/jmh<\/a>.  <\/p>\n<p>    About the Societies  <\/p>\n<p>    Journal of Men's Health is the official journal of the    International Society of Men's Health (ISMH), American Society    for Men's Health, Men's Health Society of India, and Foundation    for Men's Health. The ISMH is an international,    multidisciplinary, worldwide organization, dedicated to the    rapidly growing field of gender-specific men's health.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read the original here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2014-08\/mali-nrf080414.php\/RK=0\/RS=9LNEFYk7480PNsX4Lx9fobznFdc-\" title=\"New recommendations for post-treatment care of prostate cancer survivors\">New recommendations for post-treatment care of prostate cancer survivors<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> PUBLIC RELEASE DATE: 4-Aug-2014 Contact: Kathryn Ryan <a href=\"mailto:kryan@liebertpub.com\">kryan@liebertpub.com<\/a> 914-740-2100 Mary Ann Liebert, Inc.\/Genetic Engineering News New Rochelle, NY, August 4, 2014 -- Many of the more than 2.5 million men in the U.S. who have received treatment for prostate cancer deal with the often disabling side effects of surgery and radiation and hormonal therapies <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/new-recommendations-for-post-treatment-care-of-prostate-cancer-survivors.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[3],"tags":[],"class_list":["post-67493","post","type-post","status-publish","format-standard","hentry","category-genetic-engineering"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/67493"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=67493"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/67493\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=67493"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=67493"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=67493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}